Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
Behavioural Brain Research
|
May 22, 2024
5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptor effects on recognition memory, motor/exploratory behaviors, emotionality and regional dopamine transporter binding in the rat
Susanne Nikolaus, Owen Y Chao, Jan Henke, et al.
Pharmacology, Biochemistry, and Behavior
|
July 13, 2024
2,5-Dimethoxy-4-iodoamphetamine and altanserin induce region-specific shifts in dopamine and serotonin metabolization pathways in the rat brain
Susanne Nikolaus, Benedetta Fazari, Owen Y Chao, et al.
Scientific Reports
|
November 4, 2025
5-HT<sub>1A</sub> receptor antagonism decreases motor activity and influences dopamine and serotonin metabolization pathways, primarily in cingulate cortex and striatum
Benedetta Fazari, Susanne Nikolaus, Owen Y Chao, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 28, 2010
Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters
Timm Denecke, Patrick Hundsdörfer, Daniel Misch, et al.
Radiation Oncology (London, England)
|
September 16, 2021
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and <sup>18</sup>F-FDG PET/CT for radiotherapy target volume definition
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
Immunotherapy
|
July 13, 2022
Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors
Maja Guberina, Nika Guberina, Christoph Pöttgen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 1, 2025
Early years, advanced disease: The unmet need in young adults with non-small cell lung cancer
Maximilian Webendoerfer, Marcel Wiesweg, Jane Winantea, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2021
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY
Maja Guberina, Christoph Poettgen, Martin Metzenmacher, et al.
Respiration; International Review of Thoracic Diseases
|
April 10, 2026
Independent Validation of the LIONS PREY in Patients Undergoing Navigational Bronchoscopy
Erik Büscher, Faustina Funke, Kaid Darwiche, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 20, 2023
<sup>68</sup>Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study
David Kersting, Patrick Sandach, Miriam Sraieb, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
Behavioural Brain Research
|
May 22, 2024
5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptor effects on recognition memory, motor/exploratory behaviors, emotionality and regional dopamine transporter binding in the rat
Susanne Nikolaus, Owen Y Chao, Jan Henke, et al.
Pharmacology, Biochemistry, and Behavior
|
July 13, 2024
2,5-Dimethoxy-4-iodoamphetamine and altanserin induce region-specific shifts in dopamine and serotonin metabolization pathways in the rat brain
Susanne Nikolaus, Benedetta Fazari, Owen Y Chao, et al.
Scientific Reports
|
November 4, 2025
5-HT<sub>1A</sub> receptor antagonism decreases motor activity and influences dopamine and serotonin metabolization pathways, primarily in cingulate cortex and striatum
Benedetta Fazari, Susanne Nikolaus, Owen Y Chao, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 28, 2010
Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters
Timm Denecke, Patrick Hundsdörfer, Daniel Misch, et al.
Radiation Oncology (London, England)
|
September 16, 2021
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and <sup>18</sup>F-FDG PET/CT for radiotherapy target volume definition
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
Immunotherapy
|
July 13, 2022
Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors
Maja Guberina, Nika Guberina, Christoph Pöttgen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 1, 2025
Early years, advanced disease: The unmet need in young adults with non-small cell lung cancer
Maximilian Webendoerfer, Marcel Wiesweg, Jane Winantea, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2021
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY
Maja Guberina, Christoph Poettgen, Martin Metzenmacher, et al.
Respiration; International Review of Thoracic Diseases
|
April 10, 2026
Independent Validation of the LIONS PREY in Patients Undergoing Navigational Bronchoscopy
Erik Büscher, Faustina Funke, Kaid Darwiche, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 20, 2023
<sup>68</sup>Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study
David Kersting, Patrick Sandach, Miriam Sraieb, et al.
Page
of 11